Kennedy Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Buy	29,424 +2,415	+9%	+$30.8K	0.01%	520
2025 Q4	$243K	Buy	27,009 +495	+2%	+$6.81K	0.01%	526
2025 Q3	$458K	Buy	26,514 +13,005	+96%	+$160K	0.01%	535
2025 Q2	$127K	Buy	13,509 +496	+4%	+$4.07K	﹤0.01%	578
2025 Q1	$92.5K	Buy	13,013 +166	+1%	+$1.68K	﹤0.01%	640
2024 Q4	$150K	Buy	12,847 +2,381	+23%	+$37.2K	﹤0.01%	665
2024 Q3	$215K	Buy	+10,466	New	+$241K	﹤0.01%	673
2022 Q2	–	Sell	-3,348	Closed	-$243K	–	626
2022 Q1	$243K	Buy	3,348 +905	+37%	+$76.7K	0.01%	580
2021 Q4	$289K	Sell	2,443 -209	-8%	-$26.2K	0.01%	593
2021 Q3	$356K	Sell	2,652 -55	-2%	-$8.33K	0.01%	603
2021 Q2	$438K	Buy	+2,707	New	+$211K	0.01%	592